ENDRA Life Sciences (NDRA) Tops Q3 EPS by 1c

ENDRA Life Sciences (NASDAQ: NDRA) reported Q3 EPS of ($0.05), $0.01 better than the analyst estimate of ($0.06).

For earnings history and earnings-related data on ENDRA Life Sciences (NDRA) click here.

You May Also Be Interested In

• Meta to pay up to $16.68 billion in mass social media settlement
• J. M. Smucker (SJM) Tops Q1 EPS by 103c
• Williams-Sonoma (WSM) Tops Q2 EPS by 4c